BioPortfolio - life science, medical devices and pharmaceutical conference - Biotech, Pharma and Life Science Channel
BioPortfolio is an internet agent for Visiongain's life science, medical devices and pharmaceutical conference.
Events
BIOASIA - THE ULTIMATE 3-DAY KNOWLEDGE EXCHANGE AND NETWORKING PLATFORM FOR BUSINESS LEADERS OF LIFESCIENCES!
SELECTBIO CellTech2014 will feature an integrated program of tracks designed to fully describe the latest trends in analysis of cells, cell-based assays, and high-content phenotypic assays.
BIOLATAM 2013 - Partnering and Conference
Meeting point biotechnology business Latin American
An exhibition for producers and suppliers of raw materials and active pharmaceutical ingredients
th Annual Next Generation Sequencing Congress 2013
Over 400 Next Generation Sequencing, Genomics, Epigenetics, Genetics, Metagenomics experts from UK, Europe and USA
2nd Flow Chemistry Asia Conference of the Flow Chemistry Society aims to unite and represent those who are actively working on this rapidly developing field.
European Antibody Congress 2013
European Antibody Congress 2013 is the region’s largest event dedicated to scientific, technology and business development: an exhibition, a strategic keynote conference, real life case studies and...
2nd Annual Cell Culture & Bioprocessing Congress 2013
175 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions
3rd Annual Next Generation Sequencing Asia Congress 2013
Over 200 NGS, Genomics, Metagenomics, Epigenetics, Bioinformatics & Data Management senior scientists from Asia
11th Annual BioProduction 2013 Conference
BioProduction 2013 Announcing the Dates: 22 to 23 October 2013, The Burlington Hotel Dublin
News Articles
21st May 2013: Operating in the pharmaceutical industry requires superior data management and analytics. Pharmaceutical companies must manage large amounts of information regarding products, cust...
NovaBay’s Q113 results set the scene for a potentially transformational second half of 2013, with results expected from three Phase II studies of its topical anti-infective, auriclosene (NVC-4...
Metabolism and Environmental Degradation Studies Come Under Scrutiny at New International Conference
Leatherhead, 9 May: Smithers Viscient’s inaugural conference ‘Advances in Metabolism & Environmental Degradation Science’ will put the spotlight on current practice in th...
Edison - Evolva - Licensing deal and fund-raising - Life is sweet
The co-development deal for stevia with Cargill and the CHF31.3m equity raise in March have transformed the prospects of Evolva. In Cargill, Evolva has the ideal partner to maximise the potential of...
Edison - Arrowhead Research Corp - Financed to ARC-520 proof-of-concept data
Arrowhead’s $36m financing brings in much needed cash, as well as a group of biotech-specialist investors, which should move it up a league as it embarks on the clinical development of its hep...
Edison - Astex Pharmaceuticals - still attractive
A more than 70% appreciation in the share price over the past two months suggests the market is recognising the potential value in Astex’s internal pipeline, particularly SGI-110 – which...
Edison - Athersys - Investment summary: Gathering momentum
Athersys’ stock has gained 25% in the last month to trade at an 18-month high. We believe positive biotech sentiment in general, and burgeoning interest in stem cells and regenerative medicine...
Interview with: Cassie Schutte, Chief Executive Officer, Health Window “Pharmaceutical companies need to prove that their drugs work in the real world and that their competitors’ prod...
Interview with: Dr. Trenor Williams, Co-Founder and Chief Executive Officer, Clinovations With more than 75 per cent of physicians projected to use technology to order and prescribe medications by...
Edison - GW Pharmaceuticals NASDAQ IPO raises $31m - Long green
GW Pharmaceuticals has raised $31.2m via an IPO on NASDAQ. With pro forma cash of c £42m, GW is well capitalised to execute its commercial and R&D strategy. Our revised DCF valuation of &p...
Companies
Defymed is a spin -off of the “Centre Europeen d’etude du Diabete” (CeeD) which has been working on the conception of a bio-artificial pancreas since 1996. This work was ca...
Source BioScience LifeSciences
Source BioScience LifeSciences are European leaders in DNA sequencing, genomic services, bioinformatic analyses and offers a comprehensive portfolio of genomic reagents and antibodies. Source Bio...
With the advent of new technologies, in the last four years, DNA sequencing has gone through a technological revolution which has completely changed the market. While in 2007 it still cost over 10 m...
GL Rapha have been developing various ranges of pharmaceutical technologies specially focusing on Bio-pharmaceuticals such as recombinant proteins, synthetic peptides, and DDS bio similar based on t...
RXi Pharmaceuticals Corporation
RXi Pharmaceuticals Corporation (OTC: RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi plat...
Plandaí Biotechnology, Inc. intends to transform the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability curr...
Plasticell is a pioneering biotechnology company that specialises in the differentiation of stem cells to obtain cell types for a range of biomedical applications. Founded in 2002, Plasticell has as...
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs and vaccines. Working with some of the largest pharma...
TGR BioSciences Pty Ltd (TGR) is a private company located in Adelaide, Australia. Established in 2001, TGR is committed to providing innovative solutions for cell-based research applications. Our s...
About Pancreatic Cancer Action: 5 year survival rates for pancreatic cancer have not changed in over 40 years and it is our mission to change this by way of increased awareness of pancreatic cancer...
